Catalyst Wire Dossier Catalyst Wire Dossier

Expanded natural killer cell therapy

· University of Arkansas
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Expanded natural killer cell therapy, covering 2017-04-13 to 2017-04-13. Get the full timeline:

Most recent: Clinical Trial Update: UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma [Phase 2]

See pricing